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Abstract
Background Obesity is associated with the impairment of
immunological functions. The aim of this study was to
analyze some inflammatory mediators in obese subjects
who underwent laparoscopic cholecystectomy.
Methods Seventeen consecutive female patients with a
BMI ranging from 35 to 45 kg/m2 (obese) and 17 con-
secutive female patients with BMI ranging from 20 to
25 kg/m2 (nonobese) were included in the study. All
patients were affected by symptomatic gallbladder stone
disease and underwent laparoscopic cholecystectomy.
Changes in levels of leukocytes, neutrophils, IL-6, IL-10,
leptin, and adiponectin were evaluated.
Results We observed a significant increase in leukocyte
and neutrophil levels in the obese subjects compared to the
nonobese subjects. The serum levels of leptin and IL-6
were higher in the postoperative period (compared to the
baseline values in both groups), and always higher in the
obese. Both adiponectin and IL-10 increased in the post-
operative period in nonobese subjects and was always
higher than in the obese.
Conclusions Obese patients have a stronger acute
inflammatory response than do nonobese subjects in reac-
tion to surgical stress.
Introduction
Obesity is a pathological condition characterized by
excessive fat deposits compared to the expected values for a
given status, gender, and age and is often estimated by a
body mass index (BMI) greater than 30 [1]. Obesity is a
worldwide epidemic problem with significant adverse
effects on public health and health-care costs. Its prevalence
is increasing in all industrialized countries. It is the second
leading cause of death in the U.S., with approximately
300,000 deaths per year and an estimated total annual health
cost of $117 billion [2]. Recent data from the U.S. National
Center for Health Statistics reveal that 30% of adults over
the age of 20 are obese, approximately 60 million people.
The situation in Europe is becoming similar [1].
The disability and shortened life span associated with
obesity are consequences of comorbidity conditions,
including diabetes, hypertension, coronary heart disease,
respiratory dysfunction, cancer, and impairment of immu-
nological functions that are accompanied by a higher rate
of infections and increased risk of delayed wound healing
[3, 4], with a lower quality of life [5]. Furthermore, obesity
is also thought to be a major risk factor for postoperative
complications [6]. Some studies [6] suggested that obese
patients have a high risk of infectious complications after
surgery compared to nonobese patients; other studies [11]
reported no correlation.
Although the pathogenesis of these conditions is multi-
factorial and to date not clearly defined, it is generally
accepted that it is related, at least in part, to the metabolic
activity of adipose tissue acting via elevated levels of
inflammatory factors [14]. Adipose tissue is not only stored
energy, it is involved in a number of functions as an
endocrine organ [15]. It is known to be able to stimulate
the production of some inflammatory markers, including
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C-reactive protein (CRP) and fibrinogen, through the direct
production of proinflammatory cytokines such as interleu-
kin (IL)-6 [16]. Some proteins such as leptin and adipo-
nectin have been shown to play an important role in
regulating immune function [17].
Taking into account the above considerations, the aim of
this study was to analyze some immune-inflammatory
parameters in obese patients who underwent surgery to
explain (on the basis of biological results) the major inci-
dence of postoperative infectious complications observed in
these subjects. To avoid confounding effects linked to dif-
ferent diseases, as a surgical procedure model we chose the
response to laparoscopic cholecystectomy (LC) for benign
gallbladder disease. As we previous attested [18, 19], it is
known that simple LC induces changes of some inflam-
matory mediators. As an expression of the inflammatory
mediators, we measured changes in the levels of leukocytes,
neutrophils, IL-6, IL-10, leptin, and adiponectin.
Materials and methods
Seventeen consecutive female patients with a BMI between
35 and 45 kg/m2 and 17 consecutive female patients with a
BMI between 20 and 25 kg/m2 were enrolled in this study.
All patients were admitted to the Surgery Unit of the Sur-
gical Department of the University of Palermo from April
2005 to June 2007, and they were affected by symptomatic
and uncomplicated gallbladder stone disease. Exclusion
criteria were the presence of diabetes or endocrine, hepatic,
renal, neoplastic, inflammatory, or immunological disease.
Furthermore, patients who used drugs that could influence
the inflammatory response such as steroid or nonsteroidal
anti-inflammatory drugs and immunomodulant agents were
excluded. The study was approved by the Hospital Ethics
Committee and all patients gave written informed consent.
Patients were divided into two groups according to their
BMI. The first group included patients with BMI = 35-
45 kg/m2 (obese group) and the second group included
patients with BMI = 20-25 kg/m2 (nonobese group). Pre-
operatively, all patients received antibiotic prophylaxis with
1 g of intramuscular cefuroxime and antithrombotic pro-
phylaxis using low-molecular-weight eparine. All subjects
underwent the standard anesthetic procedures, using thio-
pental sodium for induction, vecuronium for neuromuscular
block, and isofluorane and fentanyl citrate for analgesia. All
patients underwent a laparoscopic cholecystectomy (LC).
All the operations were carried out by the same senior
surgeon (GD) with long experience in laparoscopic sur-
gery. The Anglo-Saxon technique with four trocars
was preferred, with a CO2 pneumoperitoneum maintained
at 12-14 mmHg. In all patients the telescope trocar
was introduced with the open technique through a small
sovra-umbilical incision using a special endotip trocar. An
analgesic (not an anti-inflammatory drug) was given as
postoperative analgesia as requested. Postoperative pain,
analgesic consumption, length of hospital stay, and post-
operative complications were recorded. Pain was assessed
twice daily for the first week after surgery using a linear
analog scale ranging from 0 (no pain) to 10 (worst con-
ceivable pain) [20]. Peripheral venous blood samples were
collected 24 h before surgery and then 6, 24, and 48 h after
surgery.
Absolute numbers and percentages of leukocyte blood
counts were determined using ADVIA 120 (Bayer Diag-
nostics, Munich, Germany). Sera were obtained from blood
within 30 min of venipuncture by clotting and centrifuga-
tion at 4009g for 10 min. Samples were aliquoted and
frozen at -70C until assay. For quantitative determination
of the cytokines and adipokines (IL-6, IL-10, leptin, and
adiponectin), assays were performed with commercially
available kits according to the manufacturer’s instructions
(R&D Systems Inc., Minneapolis, MN, USA). To stan-
dardize our results, in all the assays cytokine and adipokine
reference preparations were tested. These assays employed
the quantitative sandwich enzyme immune assay tech-
nique, characterized by use of monoclonal antibodies
specific for these molecules, precoated onto a solid phase.
All the standards and samples were tested in duplicate. By
using these kits, the detection limits were 7.8 pg/ml for
leptin, 0.246 ng/ml for adiponectin, 3.9 pg/ml for IL-10,
and 0.7 pg/ml for IL-6.
A sample-size calculation estimated that 17 patients
would be required in each arm to show 1 standard deviation
difference of all parameters evaluated between the obese
and nonobese groups with a power of 0.8 and alpha level of
0.05. Values are given as mean ± SD. An unpaired t test
with Welch correction was used to compare the differences
in the characteristics of the two patient groups. One-way
analysis of variance (ANOVA, corrected by Bonferroni)
was used to evaluate significant differences in the levels of
cytokines and adipokines between the two groups. Differ-
ences were considered significant when p \ 0.05. Fur-
thermore, in both groups, postoperative values were
compared to baseline values by ANOVA (corrected by
Bonferroni).
Results
Patient characteristics
Age, gender, anesthesiology grading (ASA), operative
time, length of hospital stay, BMI, and comorbidities are
given in Table 1. The only characteristic with a significant
difference between the two groups was BMI.
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Clinical outcomes
No significant differences were detected between the two
groups with respect to postoperative pain as measured on a
visual analog scale at each time point and analgesic use
(data not shown). Body temperature changes were similar
in both groups, peaking at 24 h after surgery and returning
to preoperative levels 48 h after the operation. The patients
of both groups were discharged within 72 h after the LC.
All patients had an uncomplicated postoperative course. No
patient in either group developed a wound, respiratory, or
urinary tract infection or other morbidity in the postoper-
ative period. There was no need for reoperation or blood
transfusion in either group.
Leukocyte and neutrophil counts
In both groups of patients the postoperative values of
leukocytes and neutrophils were, on the whole, signifi-
cantly higher compared to their baseline values (Table 2).
There was a significant increase in leukocyte and neutro-
phil levels preoperatively and at 6, 24, and 48 h after
surgery in obese patients compared to nonobese patients
(Table 2).
IL-6, leptin, IL-10, and adiponectin
Data on proinflammatory cytokines IL-6, IL-10, leptin, and
adiponectin are presented in Fig. 1a-d, respectively. In
general, the serum levels of both leptin and IL-6 increased
in the postoperative period compared to their baseline
values. In particular, the IL-6 level significantly increased
in the obese subjects 24 and 48 h after surgery, whereas in
the nonobese subjects a significant increase was observed
only 48 h after surgery. Interestingly, the IL-6 values of
obese patients were always higher than those in nonobese
subjects at all times (Fig. 1a). The serum levels of leptin
were significantly higher in obese patients 24 and 48 h
postoperatively compared to those of nonobese subjects at
any time point. A comparison between the two groups
showed higher values of leptin in the obese patients com-
pared to the nonobese subjects (Fig. 1c).
Overall, the serum levels of both adiponectin and IL-10
were higher in the postoperative period in the nonobese
patients, as seen in Fig. 1b and d. In particular, IL-10 was
significantly higher in nonobese patients 24 and 48 h after
cholecystectomy, whereas in the obese group its levels
showed a significant increase only at 24 h after surgery.
IL-10 levels of nonobese subjects were also higher than
Table 1 Characteristics of the
patients in the two study groups
v2 test was used to compare the
continuous variables and
unpaired t test with Welch
correction was used to compare
the differences between the two
groups
Obese group
(n = 17)
Nonobese group
(n = 17)
p value
Age [median (range)] 44.5 (20-65) 45.0 (23-67) 0.9315
BMI (kg/m2) [median (range)] 43.0 (35-45) 22 (20-25) \0.0001
ASA
I 3 3 0.9668
II 9 7 0.8538
III 4 6 0.6303
IV 1 1 0.9668
Duration of operation (min) (mean ± SD) 76.2 ± 20.1 73.8 ± 17.6 0.7101
Hospital stay (h) (mean ± SD) 50.4 ± 15.3 54.1 ± 13.7 0.4573
Hypertension 1 1 0.9668
Table 2 Leukocyte and neutrophil counts in the two study groups
Pre 6th h 24th h 48th h
Obese Nonobese Obese Nonobese Obese Nonobese Obese Nonobese
Leukocytes (absolute number) 9.9 (2.5)a 6.4 (1.1) 15.2 (2.8)a, * 8.3 (2.4) 14.6 (3.0)a, * 10.4 (2.6) 14.5 (2.6)a, * 10.1 (2.3)
Neutrophils (absolute number) 7.3 (1.2)a 4.5 (1.1) 12.9 (2.3)a 7.2 (1.0) 12.0 (1.9)a 8.3 (1.2) 11.3 (1.0)a 7.5 (1.0)
Values are mean (standard deviation)
a Comparison by unpaired t test with Welch correction of values of leukocytes and neutrophils of obese and nonobese patients at preop, 6, 24 and
48 h. A significance of p \ 0.0001 was obtained for both parameters. Within each group, one-way analysis of variance by ANOVA with
Bonferroni correction was used to analyze the differences for each time point compared to preoperative values
* Pre vs. 6: p \ 0.001; pre vs. 24, p \ 0.001; pre vs. 48, p \ 0.001 for obese group
 Pre vs. 6, p \ 0.001; pre vs. 24, p \ 0.001; pre vs. 48, p \ 0.001 for nonobese group for both parameters
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IL-10 levels of obese patients, achieving statistical signif-
icance at 24 and 48 h after operation (Fig. 1b).
Similarly, the serum levels of adiponectin reached a
significant increase postoperatively at all time points only
in nonobese patients. In addition, a significant difference in
adiponectin values was found between obese and nonobese
patients at each point examined (Fig. 1d).
Discussion
In this study, increased levels of proinflammatory markers,
including leptin and IL-6, were detected in the blood of
obese patients compared to nonobese individuals after LC.
On the other hand, levels of IL-10 and adiponectin were
lower in obese subjects compared to nonobese individuals.
The latter findings suggest that in nonobese subjects, the
inflammatory response following LC is attenuated by the
inhibitory activity of these anti-inflammatory cytokines.
All these data are in agreement with the evidence that
obesity is characterized by low-grade systemic inflamma-
tion [16, 21].
It is commonly assumed that obese patients have a
higher risk of surgical complications than do normal
subjects [7]. A few previous studies that evaluated the
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Fig. 1 a Pre- and postoperative IL-6 serum levels in obese (black
bar) and nonobese (white bar) patients. Concerning IL-6, differences
between baseline and postoperative values were observed only at 48 h
(p \ 0.001 by ANOVA test with Bonferroni’s correction) in nonob-
ese patients. In obese patients, the differences between baseline and
postoperative values were significant at 24 and 48 h (p \ 0.01 and
p \ 0.001, respectively, by ANOVA test with Bonferroni’s correc-
tion). In addition, significance was achieved comparing values of
nonobese and obese patients at all times after operation (p \ 0.001 by
ANOVA test with Bonferroni’s correction). b Pre- and postoperative
IL-10 serum levels in obese (black bar) and nonobese (white bar)
patients. A significant increase between baseline and postoperative
values was observed at 24 and 48 h (p \ 0.001 and p \ 0.001,
respectively, by ANOVA test with Bonferroni’s correction) in
nonobese patients. In obese patients, the differences between baseline
and postoperative values were significant only at 24 h (p \ 0.01 by
ANOVA test with Bonferroni’s correction). In addition, significance
was achieved comparing values of nonobese and obese patients at 24
and 48 h after operation (p \ 0.01 and p \ 0.001, respectively, by
ANOVA test with Bonferroni’s correction). c Pre- and postoperative
leptin serum levels in obese (black bar) and nonobese (white bar)
patients. A significant increase between baseline and postoperative
values was observed only at 24 and 48 h (p \ 0.05 and p \ 0.001,
respectively, by ANOVA test with Bonferroni’s correction) in obese
patients. In nonobese patients, the leptin postoperative values
were not significantly higher when compared to baseline values.
In addition, significance was obtained comparing values of nonobese
and obese patients at all times after operation (p \ 0.01, p \ 0.001,
p \ 0.001, and p \ 0.0001, respectively, by ANOVA test with
Bonferroni’s correction) d Pre- and postoperative adiponectin serum
levels in obese (black bar) and nonobese (white bar) patients.
A significant increase in adiponectin postoperative values compared
to the baseline values was observed only in nonobese patients at 6, 24,
and 48 h (p \ 0.05, p \ 0.01, and p \ 0.001, respectively, by
ANOVA test with Bonferroni’s correction). In obese patients the
adiponectin postoperative values were not significantly higher
compared to baseline values. In addition, significance was found
when the values of nonobese and obese patients at all times after
operation were compared (p \ 0.001 by ANOVA test with Bonfer-
roni’s correction)
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impact of obesity on perioperative outcome produced
questionable results [7]. Bangbade et al. [6], in their ret-
rospective review of 7271 cases of postoperative compli-
cations after major or moderate noncardiac surgery,
showed that obese patients had a higher prevalence of
myocardial infarction, peripheral nerve injury, wound
infection, and urinary tract infection, with a mortality rate
of 2.2% compared to 1.2% for normal subjects [6]. Dindo
et al. [7] investigated how obesity affected outcome of
elective general surgery in a cohort of more than 6000
patients followed prospectively over 10 years. They sug-
gested that obese patients face a higher risk for surgical
site infections after open surgery, probably related to the
presence of excessive fat tissue which, in their opinion,
may predispose the patient to impaired wound healing and
infections in the presence of concomitant factors such as
hematoma [7]. Furthermore, Tanaka et al. [8] showed that
obese patients have an underlying immune impairment in
lymphocyte responsiveness which might contribute to
higher rates of wound infections [8]. More recently, data
collected from a review examining the impact of obesity
on postoperative morbidity after colorectal surgery [9]
suggested that obesity represents a significant risk factor
for wound infections, anastomotic leakage, and pulmonary
and thromboembolic problems [9]. Accordingly, in a
multivariate analysis of 608 patients who underwent
digestive tract surgery, subjects with BMI [ 30 had an
adjusted odds ratio (OR) for surgical site infections of 4.8
[10]. Conversely, a retrospective review by Ondrula et al.
[11] of 960 colorectal procedures performed during a
5-year period found that obesity was not significantly
associated with wound infections [11]. Also, similar
results have been observed after cardiac surgery [12].
Finally, Mullen et al. [13] even suggested that after non-
bariatric general surgery, overweight and obese patients
may paradoxically have better outcomes than normal-
weight patients.
Recently, both clinical and experimental studies showed
that obesity produced immune response impairment [4, 8,
22]. In particular, Chandra and Au [22] found that 38% of
obese children showed variable impairment of cell-medi-
ated immune responses such as delayed cutaneous hyper-
sensitivity, abnormal lymphoproliferative response to
mitogens, and a reduction in intracellular bacteria-killing
capacity by polymorphonuclear leukocytes. Some reports
have also linked obesity to a lower production of antibodies
after hepatitis B vaccination [23].
The current view of adipose tissue is that it is an active
secretor organ able to produce immune-related proteins,
including cytokines, adipokines, fibrinogen, and acute
phase proteins such as CRP [16]. Leptin is a cytokine that
has a fundamental role in the regulation of food intake and
energy balance [16], with a crucial function in regulating
immunity [24]. In particular, leptin protects T lymphocytes
from apoptosis and regulates T-cell proliferation and acti-
vation [21]. It also influences cytokine production from
T lymphocytes, monocyte activation, and phagocytosis
[21]. Thus, leptin acts as a proinflammatory cytokine and
its circulating levels directly correlate with adipose tissue
mass [25]. On the other hand, adiponectin, although
released by adipocytes, does not increase with obesity; its
levels are reduced in obese subjects [22]. Adiponectin acts
as an anti-inflammatory by inhibiting IL-6 production
accompanied by induction of the anti-inflammatory cyto-
kines IL-10 and IL-1 receptor antagonist [26].
Our results indicate that obese patients have a stronger
acute inflammatory response than do nonobese subjects
after surgical stress. The severity of surgical stress varies in
accordance with the host response after surgical procedures.
Proinflammatory cytokines are thought to mediate surgical
stress, with neurohumoral response assumed to be regulated
by the production of cytokines [27]. The complex cascade of
acute-phase response, regulated by an adequate balance of
inflammatory mediators, is also designed to isolate and
destroy microbial pathogens, to activate tissue repair pro-
cesses, and to facilitate a return to physiological homeo-
stasis [28]. Therefore, when there is hyperactivity in the
acute-phase response due to an increase in the inflammatory
mediators, as we observed in obese patients, there is an
elevated risk of immune impairment that could be respon-
sible for an increase in postoperative complications [27, 29].
The clinical significance of our results remains unclear
because our study is only observational. Hence, we cannot
conclude that there is a causal relationship between the
cytokines leptin and adiponectin and acute-phase response
and the increased susceptibility to postoperative compli-
cations observed in obese patients. However, it must be
taken into account that it has been claimed that proin-
flammatory mediators as well as cytokines and leptin play
an important role in the pathogenesis of postoperative
complications [30].
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